Australia markets open in 2 hours 12 minutes

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
42.05-0.07 (-0.17%)
At close: 04:00PM EDT
42.05 0.00 (0.00%)
After hours: 04:04PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
45,702
25,445
58,266
-386,653
Depreciation & amortisation
33,679
32,127
25,915
23,680
Deferred income taxes
17,379
16,802
23,200
-38,413
Change in working capital
66,218
-37,907
-279,027
460,659
Accounts receivable
53,431
37,482
-6,229
21,683
Inventory
7,208
-16,922
-2,069
-27,219
Accounts payable
-
1,649
-2,129
32,308
Other working capital
86,001
11,903
-270,016
28,618
Other non-cash items
-
-15,292
-
-
Net cash provided by operating activities
142,868
31,750
-158,698
45,770
Cash flows from investing activities
Investments in property, plant and equipment
-56,867
-19,847
-111,318
-17,152
Purchases of investments
-1,253,945
-972,155
-875,789
-1,132,501
Sales/maturities of investments
1,053,253
866,446
809,119
1,217,386
Other investing activities
-
-
-99,275
8
Net cash used for investing activities
148,213
-125,556
-170,581
67,741
Cash flows from financing activities
Common stock repurchased
-
0
-24,934
-24,196
Dividends paid
-
-
-
0
Net cash used provided by (used for) financing activities
-
0
-24,934
-24,196
Net change in cash
290,436
-96,639
-354,043
91,823
Cash at beginning of period
91,973
251,134
605,177
513,354
Cash at end of period
383,054
154,495
251,134
605,177
Free cash flow
Operating cash flow
142,868
31,750
-158,698
45,770
Capital expenditure
-56,867
-19,847
-111,318
-17,152
Free cash flow
86,001
11,903
-270,016
28,618